These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6380905

  • 1. Walking capacity of patients with intermittent claudication during chronic antihypertensive treatment with metoprolol and methyldopa.
    Lepäntalo M, von Knorring J.
    Clin Physiol; 1984 Aug; 4(4):275-82. PubMed ID: 6380905
    [Abstract] [Full Text] [Related]

  • 2. Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication.
    Lepäntalo M.
    Br J Clin Pharmacol; 1984 Jul; 18(1):90-3. PubMed ID: 6378235
    [Abstract] [Full Text] [Related]

  • 3. Beta blockade and intermittent claudication.
    Lepäntalo M.
    Acta Med Scand Suppl; 1985 Jul; 700():1-48. PubMed ID: 2865873
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial.
    Muiesan G, Agabiti-Rosei E, Alicandri C, Motolese M.
    Clin Exp Pharmacol Physiol Suppl; 1978 Jul; 4():35-41. PubMed ID: 354827
    [Abstract] [Full Text] [Related]

  • 5. The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication.
    Svendsen TL, Jelnes R, Tønnesen KH.
    Acta Med Scand; 1986 Jul; 219(2):161-5. PubMed ID: 3515864
    [Abstract] [Full Text] [Related]

  • 6. Comparative study of metoprolol and alpha-methyldopa in untreated essential hypertension.
    Bergstrand RH, Vedin JA, Wilhelmsson CE, Berglund G.
    Eur J Clin Pharmacol; 1976 Jul; 10(6):375-9. PubMed ID: 793848
    [Abstract] [Full Text] [Related]

  • 7. Effect of exercise in hypertension controlled with metoprolol or methyldopa.
    Stoker JB, Sreeharan N, Linden RJ, Barbour MP, Lorimer AR, Hillis WS, Lawrie TD.
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():391s-392s. PubMed ID: 540459
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN.
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [Abstract] [Full Text] [Related]

  • 9. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G, Agabiti-Rosei E, Buoninconti R, Carotti A, Fariello R, Innocenti P, Solinas E, Toso M, Motolese M.
    G Ital Cardiol; 1980 Sep; 10(11):1482-90. PubMed ID: 7202896
    [Abstract] [Full Text] [Related]

  • 10. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C, Weisser G, Jagodzinski A, Savvidis S, Warnholtz A, Ostad MA, Gori T, Munzel T.
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [Abstract] [Full Text] [Related]

  • 11. Double-blind comparison of captopril with nifedipine in hypertension complicated by intermittent claudication.
    Roberts DH, Tsao Y, Linge K, McLoughlin GA, Breckenridge A.
    Angiology; 1992 Sep; 43(9):748-56. PubMed ID: 1514711
    [Abstract] [Full Text] [Related]

  • 12. [Protection of the hypertensive patient: comparative study of atenolol and metoprolol].
    Mazzari M, Coppola E, Montenero AS, Schiavoni G, Domenichelli B, Mongiardo R, Pennestrì F.
    Cardiologia; 1982 Sep; 27(8):753-63. PubMed ID: 6765444
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension.
    Leonetti G, Mazzola C, Boni S, Guffanti E, Meani A, Zanchetti A.
    Eur J Clin Pharmacol; 1986 Sep; 30(6):637-40. PubMed ID: 3533561
    [Abstract] [Full Text] [Related]

  • 14. Effect of beta-blockade on exercise capacity in hypertensive subjects: a one-year double-blind study of celiprolol and metoprolol.
    Vyssoulis GP, Kouremetis MT, Valiouli MA, Michaelides AP, Toutouzas PK.
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):133-9. PubMed ID: 7786833
    [Abstract] [Full Text] [Related]

  • 15. beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination.
    Solomon SA, Ramsay LE, Yeo WW, Parnell L, Morris-Jones W.
    BMJ; 1991 Nov 02; 303(6810):1100-4. PubMed ID: 1747577
    [Abstract] [Full Text] [Related]

  • 16. Placebo-controlled trial of ketanserin in the treatment of intermittent claudication.
    Cameron HA, Waller PC, Ramsay LE.
    Angiology; 1987 Jul 02; 38(7):549-55. PubMed ID: 3304029
    [Abstract] [Full Text] [Related]

  • 17. Comparison of trimazosin and methyldopa in hypertension.
    Aronow WS, Tobis J, Hughes D, Siegel J, Easthope J.
    Clin Pharmacol Ther; 1977 Oct 02; 22(4):425-9. PubMed ID: 332438
    [Abstract] [Full Text] [Related]

  • 18. Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with metoprolol in a crossover double-blind trial.
    Trimarco B, DeLuca N, Ricciardelli B, Volpe M, Veniero A, Cuocolo A, Cicala M.
    J Clin Pharmacol; 1984 Oct 02; 24(5-6):218-27. PubMed ID: 6378988
    [Abstract] [Full Text] [Related]

  • 19. Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
    Roberts DH, Tsao Y, McLoughlin GA, Breckenridge A.
    Lancet; 1987 Sep 19; 2(8560):650-3. PubMed ID: 2887941
    [Abstract] [Full Text] [Related]

  • 20. Crossover comparison of sotalol plus methyldopa in hypertension.
    Scrazzolo JE, Queirol AG.
    J Clin Pharmacol; 1979 Sep 19; 19(8-9 Pt 2):540-6. PubMed ID: 385637
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.